Apply now for the 2025 Mark Foundation Emerging Leader Award! Grants are awarded to early-career investigators in US and Canada for projects addressing unmet needs in cancer research. Deadline to apply is April 29. For more information, please visit bit.ly/3Iw678s

You might have forgotten about Covid but immunocompromised patients have not. Check out our latest paper on the subject. Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination - onlinelibrary.wiley.com/doi/10.1002/ac…

Kicking off our coverage with Dr. Michelle Krogsgaard of NYU Langone Health, who just spoke with us about the optimization of neoantigen targets for shared and personalized anticancer vaccine development. Thanks for a fantastic interview! NYAS The Tisch Cancer Institute #cancerimmunotherapy #oncology

Sich a start this morning! With impressive talks from Robert Tampé and Dr. Michelle Krogsgaard! The beauty of TCR structure will never end...

Amazing meeting in Tuscany for all the B and T cell aficionados 🧫

Our latest study on the in situ cell-surface conformation of the TCR-CD3 signaling complex | EMBO reports embopress.org/doi/full/10.10…

Read our latest review on Phosphopeptide Neoantigens as Emerging Targets in Cancer Immunotherapy🧬🧫 doi.org/10.33696/cance… Perlmutter Cancer Center at NYU Langone Health NYU Langone Health

Paolo Ascierto's symposium on adjuvant therapy in melanoma ends with a tribute to Jeffrey S. Weber, "an incredible scientist and a great friend" #bridge2024 #Melanoma Paolo A. Ascierto

Michelle Krogsgaard on improving mRNA vaccine in #melanoma #bridge2024 Dr. Michelle Krogsgaard

Join us in Greece 🧬🧫

Thank you!!!

Exactly!

Protect Biomedical Research and Innovation congressweb.com/AIMBE/4?framed… #

Thank you to National Cancer Institute for highlighting our study. Perlmutter Cancer Center at NYU Langone Health NYU Langone Health

Explore this gift article from The New York Times. You can read it for free without a subscription. nytimes.com/2025/02/14/opi…

The AACR is deeply concerned that the Administration’s recent actions are threatening NIH and its mission to accelerate progress for patients with cancer and other diseases that afflict millions of Americans. We urge Congress to restore stability to NIH: brnw.ch/21wQMO3

thetransmitter.org/funding/federa…

Urge Congress to Support NIH and Protect Medical Research votervoice.net/Shares/BM8FmAI…

Please stop!!

When the organizers ask if you can send in your slides a week before the conference